Top of page Skip navigation
  • ONLY FOUR WEEKS TO GO

    Register today...

  • WE'RE GETTING READY TO PARTNER

    Will you be joining us?

  • RAISE YOUR ORGANISATIONS PROFILE

    Exhibitor packages available - reserve your space today

Confirmed speakers so far include:

  • Dr Peter Atkinson, Associate Director, Head of UK Open Innovation - Neurology Business Group, Eisai
  • Nicola Baker-Munton, Chief Executive Officer, Stratagem IPM
  • Laurence Barker, Chief Business Officer, Dementia Discovery Fund, SV Health Investors
  • Steve Bates OBE, Chief Executive Officer, BIA  
  • Professor Sir John Bell, Regius Professor of Medicine, Oxford University 
  • Dr Aleksandra Berditchevskaia, European Coordination and Knowledge Transfer Manager, Tekiu
  • Dr Veronique Birault, Head, Translational Science, The Francis Crick institute
  • Sue Charles, Partner, Instinctif Partners Life Sciences
  • Laura Collister, Brexit Lead, BIA
  • Jeremy Curnock Cook, Managing Director, BioScience Managers
  • Dr John Davis, Chief Scientific Officer, ARUK Drug Discovery Alliance
  • Professor Paul Davis, Co-Founder and Chief Scientific Officer, Mologic and Honorary/Visiting Professor, Universities of Cardiff, Kent and Warwick
  • Dr Kit Erlebach, Head of R&D Continuous Improvement, FUJIFILM Diosynth Biotechnologies 
  • Simon Ellison, Cell and Gene Therapy Service Director, World Courier
  • Laura Ferguson, Chief Executive Officer, Capital Cell
  • Dr James Field, Founder and Chief Executive Officer, LabGenius
  • Dr Steve Flatman, Head of Research and Devleopment Clinical Development Manufacturing, Lonza
  • Dr Chris Gardner, Partner, Consilium Strategic Communications
  • Professor Joanna Hackett, Commercial Director, Genomics England
  • Dr Ed Hodgkin, Partner, Syncona Partners
  • Alice Hu Wagner, Managing Director, Strategy Economics and Business Development, British Business Bank
  • Dr Matthew Hallsworth, Head of External Relations, NIHR
  • Prof Jim Huntingdon, Professor of Molecular Haemostasis, Cambridge University
  • Andrew Hutchinson, Partner, Simmons & Simmons
  • Dr Adrian Ibrahim, Head of Technology Transfer and Business Development, Sanger Institute 
  • Nicole Jadjea, Partner, Fieldfisher 
  • Dr Panos Kefalas, Head of Health Economics and Market Access, Cell and Gene Therapy Catapult
  • Sarah Kerruish, Chief Patient Officer, Antidote
  • Dr Sven Kili, Vice President and Head of Cell and Gene Therapy Development, GlaxoSmithKline
  • Charles Mayo, Partner, Simmons & Simmons
  • Susie Middlemiss, Partner, Slaughter and May 
  • Dr Jim Mills, Vice President Technical Operations, Abzena
  • Gareth Morgan, Partner CMS Cameron McKenna Nabarro Olswang
  • Andy Morris, Patient Advocate
  • Alan Morrison, Vice President International Regulatory Affairs, MSD 
  • Dr Jennifer O’Farrell, Partner, Boult Wade
  • Dr Angela Osborne, Managing Director, eXmoor Pharma Concepts
  • Dr Vijay Reddy, Chief Medical Officer, Autolus
  • Dr David Reynolds, Chief Scientific Officer, Alzheimer’s Research UK
  • Hanno Ronte, Partner, Monitor Deliotte 
  • Professor Nigel Silman, Senior Business Development Manager, Public Health England and Visiting Professor, University of West England   
  • Dr Angela Silmon, Chief Executive Officer, NewGene 
  • Michael Tappin QC, 8 New Street Square
  • Raphael Tschanz, Deputy Chief Executive Officer, Switzerland Innovation
  • Huw Tippett, Independent Consultant (formerly of Baxalta and Novartis)
  • Jonathan Tobbin, Investment Manager, Arix Biosciences
  • Paul Tomasic, Managing Director, European Head of Healthcare, RBC Capital Markets 
  • Dr Penny Ward, Chief Medical Officer, Karus Therapeutics 
  • Dr Will West, Executive Chairman, CellCentric and BIA Board 
  • Doris-Ann Williams MBE, Chief Executive, British in vitro Diagnostics Association
  • Kirsty Wydenbach, Deputy Unit Manager and Senior Medical Assessor Clinical Trials Unit, MHRA
  • Einat Zisman, Chief Executive Officer, Futurx